David Stoll, MD
Dermatology · Santa Monica, CANPI 1457330169
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations.
Across 173 payments — averaging $24.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1000
- Amgen$467
- Merz North America, Inc.$466
- Lilly USA, LLC$300
- LEO Pharma Inc.$266
- E.r. Squibb & Sons, L.L.C.$239
- plus $2K from 18 others
Across 164 payments — averaging $14,188 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$881K
- Eli Lilly$667K
- Janssen Research & Development, LLC$243K
- UCB SA$152K
- LEO Pharma AS$139K
- Amgen$116K
- plus $128K from 4 others
What the payments were for
- Food & beverage$4,250100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 55 | $1,000 |
| Amgen | 23 | $467 |
| Merz North America, Inc. | 3 | $466 |
| Lilly USA, LLC | 12 | $300 |
| LEO Pharma Inc. | 8 | $266 |
| E.r. Squibb & Sons, L.L.C. | 13 | $239 |
| Johnson & Johnson | 7 | $174 |
| Incyte Corporation | 8 | $155 |
| AbbVie(2 entities) | 6 | $153 |
| Dermavant Sciences, Inc. | 5 | $142 |
| Zimmer Biomet | 1 | $126 |
| UCB, Inc. | 4 | $120 |
| Arcutis Biotherapeutics, Inc. | 5 | $112 |
| Galderma Laboratories, L.p. | 5 | $110 |
| EPI Health, LLC | 5 | $103 |
| Sun Pharmaceutical Industries Inc. | 2 | $83 |
| Novartis | 2 | $45 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $39 |
| Organon | 1 | $29 |
| Revance Therapeutics, Inc. | 1 | $27 |
| Mission Pharmacal Company | 2 | $26 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$466
- Juggerknotless Soft Anchor$126
How this compares
$4,250 in reported general payments places this provider in the 65th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tretinoin | 21 | $1,940 |
| Fluocinonide | 57 | $1,485 |
| ValacyclovirValacyclovir Hcl | 15 | $1,082 |
| Betamethasone Dipropionate | 27 | $1,068 |
| Alclometasone Dipropionate | 26 | $803 |
| Clobetasol Propionate | 23 | $739 |
| CiclopiroxCiclopirox Olamine | 37 | $717 |
| Triamcinolone Acetonide | 78 | $677 |
| Ciclopirox | 17 | $613 |
| Minoxidil | 25 | $429 |
| Ketoconazole | 14 | $358 |
| Clindamycin Phosphate | 12 | $343 |
| Mupirocin | 41 | $297 |
| Hydrocortisone | 12 | $64 |
| Cephalexin | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Santa Monica
- Paul YamauchiSanta Monica$2.9M
- Ava ShambanSanta Monica$204K
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.